Zeo ScientifiX, Inc.

ZEOX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Revenue $569.8K $184.9K $147.6K $49.2K $83.0K $87.1K $18.1K
Cost of Revenue $160.6K $94.4K $49.4K $20.1K $44.4K $61.1K $11.0K
Gross Profit $409.2K $90.5K $98.2K $29.1K $38.5K $26.0K $7.1K
Gross Margin 71.8% 48.9% 66.5% 59.2% 46.4% 29.9% 39.2%
Operating Expenses
Research & Development
SG&A Expense $9.1M $1.1M $842.5K $95.0K $43.7K $14.5K $5.6K
Operating Income $-8.6M $-1.0M $-744.3K
Operating Margin -1,516.5% -564.3% -504.2%
Interest Expense $576.0K $12.7K
Pretax Income $-9.1M
Income Tax Expense $0 $0
Net Income $-9.0M $-1.3M $-738.4K $-65.8K $-32.2K $-13.3K $-11.7K
Net Margin -1,574.5% -677.8% -500.1% -133.8% -38.8% -15.3% -64.9%
EPS (Basic) $-0.08 $-0.01 $-0.01 $0.00 $0.00
EPS (Diluted) $-0.08 $-0.01 $-0.01 $0.00 $0.00
Shares Outstanding (Basic) 111.5M 104.2M 99.2M 150.1M 7.8M
Shares Outstanding (Diluted) 111.5M 104.2M 99.2M 150.1M 7.8M
Dividends Per Share
← Newer Page 2 of 2 Older →